Moreover, we further demonstrated that IGFBP3 is an important downstream target gene of B-Myb, and that B-Myb activates extracellular signal-regulated kinases (ERK) and Akt signaling at least partially through inhibiting IGFBP3 in NSCLC cells. Here, IGFBP3 is linked to non-small cell lung carcinoma.